Results 141 to 150 of about 34,038 (203)

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active. [PDF]

open access: yesNat Commun
Sequera C   +24 more
europepmc   +1 more source

Successful Reswitching of Thrombopoietin Receptor Agonists: Two Cases of Immune Thrombocytopenia and Severe Aplastic Anemia. [PDF]

open access: yesIntern Med
Itoh K   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy